Abstract:A series of novel pleuromutilin derivatives possessing 1,2,3-triazole moieties were synthesized via click reactions under mild conditions. The in vitro antibacterial activities of these derivatives against 4 strains of S. aureus (MRSA ATCC 43300, ATCC 29213, AD 3, and 144) and 1 strain of E. coli (ATCC 25922) were tested by the broth dilution method. The majority of the synthesized derivatives displayed potent antibacterial activities against MRSA (MIC = 0.125 ∼ 2 μg/mL). It was also found that most compounds had no significant inhibitory effect on the proliferation of RAW264.7 cells at the concentration of 8 μg/mL. Among these derivatives, compound 32 (∼1.71 log10 CFU/g) containing dimethylamine group side chain displayed more effective than tiamulin (∼0.77 log10 CFU/g) at the dose of 20 mg/kg in reducing MRSA load in thigh infected mice. Additionally, compound 32 (the survival rate was 50%) also displayed superior in vivo efficacy to that of tiamulin (the survival rate was 20%) in the mouse systemic model. Structure-activity relationship (SAR) studies resulted in compound 32 with the most potent in vitro and in vivo antibacterial activity among the series. Moreover, compound 32 was evaluated in CYP450 inhibition assay and showed moderate in vitro inhibition of CYP3A4 (IC50 = 6.148 μM).

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives

Design, Synthesis and Antibacterial Evaluation of Pleuromutilin Derivatives

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives with Quinazolinone and Thioether Groups

Synthesis And Biological Evaluation Of New Pleuromutilin Derivatives As Antibacterial Agents

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives with Thiazole-5-Carboxamide and Thioether Moiety

Chemical Synthesis And Biological Activities Of Novel Pleuromutilin Derivatives With Substituted Amino Moiety

ChemInform Abstract: Synthesis and Antibacterial Activities of Pleuromutilin Derivatives with Quinazolinone and Thioether Groups.

Synthesis and biological evaluation of novel pleuromutilin derivatives with nitrogen-containing heterocycles as antibacterial agents

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives Containing Aryl Urea Groups

Synthesis and Biological Activities of Novel Pleuromutilin Derivatives with a Substituted Thiadiazole Moiety As Potent Drug-Resistant Bacteria Inhibitors

Design, synthesis and antibacterial activity evaluation of pleuromutilin derivatives according to twin drug theory

Discovery of novel pleuromutilin derivatives as potent antibacterial agents

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives with Modified 7-Aminocephalosporin Acid and Thioether Moiety

Design, synthesis, and antibacterial activity of pleuromutilin derivatives

Synthesis and Antibacterial Activity of Alkylamine-Linked Pleuromutilin Derivatives

Novel Pleuromutilin Derivatives with Excellent Antibacterial Activity Against Staphylococcus Aureus

Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety

Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents

Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups

Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents

Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation